136 related articles for article (PubMed ID: 37042461)
1. Conjunctival Melanoma in Aotearoa-New Zealand: A 21-Year Analysis of Incidence and Survival.
Lim JZ; Misra SL; Gokul A; Hadden PW; Cavadino A; McGhee CNJ
Asia Pac J Ophthalmol (Phila); 2023 May-Jun 01; 12(3):273-278. PubMed ID: 37042461
[TBL] [Abstract][Full Text] [Related]
2. The Burden of Histologically Confirmed Uveal Melanoma in Aotearoa-New Zealand: A 21-year Review of the National Cancer Registry.
Lim JZ; Gokul A; Misra SL; Hadden PW; Cavadino A; McGhee CNJ
Asia Pac J Ophthalmol (Phila); 2023 Jul-Aug 01; 12(4):384-391. PubMed ID: 37523430
[TBL] [Abstract][Full Text] [Related]
3. Incidence and Survival of Patients With Conjunctival Melanoma in Europe.
Virgili G; Parravano M; Gatta G; Capocaccia R; Mazzini C; Mallone S; Botta L;
JAMA Ophthalmol; 2020 Jun; 138(6):601-608. PubMed ID: 32215588
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous melanoma in New Zealand: 2000-2004.
Liang JJ; Robinson E; Martin RC
ANZ J Surg; 2010 May; 80(5):312-6. PubMed ID: 20557503
[TBL] [Abstract][Full Text] [Related]
5. Incidence trends of conjunctival malignant melanoma in Canada.
Ghazawi FM; Darwich R; Le M; Jfri A; Rahme E; Burnier JV; Sasseville D; Burnier MN; Litvinov IV
Br J Ophthalmol; 2020 Jan; 104(1):23-25. PubMed ID: 31079055
[TBL] [Abstract][Full Text] [Related]
6. Malignant melanoma amongst Maori and New Zealand Europeans, 2000-2004.
Hore T; Robinson E; Martin RC
World J Surg; 2010 Aug; 34(8):1788-92. PubMed ID: 20401482
[TBL] [Abstract][Full Text] [Related]
7. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of cutaneous melanoma and keratinocyte cancer in white populations 1943-2036.
Garbe C; Keim U; Gandini S; Amaral T; Katalinic A; Hollezcek B; Martus P; Flatz L; Leiter U; Whiteman D
Eur J Cancer; 2021 Jul; 152():18-25. PubMed ID: 34062483
[TBL] [Abstract][Full Text] [Related]
9. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
10. Exploring melanoma shifts: a two-decade analysis in New Zealand.
Wen D; Pullman JS; Sharma A; van der Werf B; Martin RCW
N Z Med J; 2024 Jun; 137(1596):35-42. PubMed ID: 38843548
[TBL] [Abstract][Full Text] [Related]
11. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
Buettner PG; Leiter U; Eigentler TK; Garbe C
Cancer; 2005 Feb; 103(3):616-24. PubMed ID: 15630700
[TBL] [Abstract][Full Text] [Related]
12. Incidence of malignant melanoma in Auckland, New Zealand: highest rates in the world.
Jones WO; Harman CR; Ng AK; Shaw JH
World J Surg; 1999 Jul; 23(7):732-5. PubMed ID: 10390596
[TBL] [Abstract][Full Text] [Related]
13. Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040.
Arnold M; Singh D; Laversanne M; Vignat J; Vaccarella S; Meheus F; Cust AE; de Vries E; Whiteman DC; Bray F
JAMA Dermatol; 2022 May; 158(5):495-503. PubMed ID: 35353115
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer).
Katalinic A; Kunze U; Schäfer T
Br J Dermatol; 2003 Dec; 149(6):1200-6. PubMed ID: 14674897
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society.
Garbe C; Orfanos CE
Pigment Cell Res; 1992; Suppl 2():285-94. PubMed ID: 1409431
[TBL] [Abstract][Full Text] [Related]
16. Second Primary Malignancies following a Diagnosis of Conjunctival Melanoma.
Mahjoub H; Loya A; Ayaz T; Weng CY
Curr Eye Res; 2022 Apr; 47(4):634-641. PubMed ID: 34898336
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Sex-Specific Incidence of Melanoma.
Olsen CM; Thompson JF; Pandeya N; Whiteman DC
JAMA Dermatol; 2020 May; 156(5):553-560. PubMed ID: 32211827
[TBL] [Abstract][Full Text] [Related]
18. Time trends in the incidence of conjunctival melanoma in Sweden.
Triay E; Bergman L; Nilsson B; All-Ericsson C; Seregard S
Br J Ophthalmol; 2009 Nov; 93(11):1524-8. PubMed ID: 19628487
[TBL] [Abstract][Full Text] [Related]
19. Annual Report to the Nation on the Status of Cancer, Part 1: National Cancer Statistics.
Islami F; Ward EM; Sung H; Cronin KA; Tangka FKL; Sherman RL; Zhao J; Anderson RN; Henley SJ; Yabroff KR; Jemal A; Benard VB
J Natl Cancer Inst; 2021 Nov; 113(12):1648-1669. PubMed ID: 34240195
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors and incidence of primary mucosal melanoma: a population-based study in France.
Beaudoux O; Riffaud L; Barbe C; Grange F
Eur J Dermatol; 2018 Oct; 28(5):654-660. PubMed ID: 30378540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
